Notice
Check the various announcements of oncoMASTER.
2024.02.07 14:39
[oncoMASTER Director's press release] "Relaxation of university shareholding ratio, development of medical school professor-pharmaceutical cooperation ecosystem" (2022. 09. 22. Medical Times) “Relaxation of university ownership ratio, development of medical school professor-pharmaceutical cooperation ecosystem” Pharmaceutical companies such as Hanmi and Yuhan Corporation expand investment in digital health and ESG After 2020, technology holding company subsidiary shareholding will be relaxed from 20% to 10%. Yuhan Corporation invests 2 billion won in ‘Onco Master’ and acquires 8.0% stake link https://www.medicaltimes.com/Main/News/NewsView.html?ID=1149587&ref=naverpc Source: Medical Times (Reporter Seongho Moon_2022. 09. 22)
ONCOCROSS Co., Ltd.
Business registration number: 482-86-00109 | CEO: Yi Rang KIM / Jihoon KANG
Address: Room 905, 7 Beobwon-ro 11-gil, Songpa-gu, Seoul, Korea (Munjeong-dong, Munjeong Hyundai Knowledge Industry Center 1-2)
Email: oncocross@oncocross.com
ⓒ ONCOCROSS CO., LTD. All Rights Reserved.